News und Analysen
![Eilt: 100 mal wirksamer gegen Krebs - Hautkrebs vollständig geheilt. Neuer 407% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73679/aktiencheck22022401.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBelk3YkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--a0a0d75690ccfcc8e8ad82a24a0e1311269b65a8/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/aktiencheck22022401.001.png?locale=de)
Eilt: 100 mal wirksamer gegen Krebs - Hautkrebs vollständig geheilt. Neuer 407% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: 100 mal wirksamer gegen Krebs - Hautkrebs vollständig geheilt. 400% Biotech Aktientip nach 9.290% mit Novo-Nordisk
22.02.24
London (www.aktiencheck.de, Anzeige)
![3 Reasons the Capital One-Discover merger is a big deal: https://www.marketbeat.com/logos/articles/med_20240221114956_3-reasons-the-capital-one-discover-merger-is-a-big.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM0E2YkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--f0cd7235043a4f96645ac4d5b9c1d5c54162f454/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240221114956_3-reasons-the-capital-one-discover-merger-is-a-big.jpg?locale=de)
3 Reasons the Capital One-Discover merger is a big deal
What’s in your wallet? In the not-so-distant future, it might be a card issued by the combined entity of Capital One Financial Corp. (NYSE: COF) and Discover Financial Services (NYSE: DFS).
![Spotify sounding better to analysts as company tunes into profits: https://www.marketbeat.com/logos/articles/med_20240220131029_spotify-sounding-better-to-analysts-as-company-tun.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK001YkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9d61c792864198a299fd0c96b6110807c7e02c0d/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240220131029_spotify-sounding-better-to-analysts-as-company-tun.jpg?locale=de)
Spotify sounding better to analysts as company tunes into profits
Spotify Technology S.A. (NYSE: SPOT) is trading at its best levels since December 2021 on the strength of hardy revenue growth and a return to profitability.
Spotify is a global music streaming
![Informatica charges ahead on AI-driven data management tailwinds: https://www.marketbeat.com/logos/articles/med_20240218153655_charts-infa.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK1k1YkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--af543a666ccb778cc32b574e5260178391f3a94f/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240218153655_charts-infa.jpg?locale=de)
Informatica charges ahead on AI-driven data management tailwinds
Informatica Inc. (NASDAQ: INFA) offers its artificial intelligence (AI) platform for enterprises to unify and manage their data to unlock transformative outcomes. The computer and technology
![Eilt: Durchbruch in Krebsforschung: 100 mal wirksamer gegen Krebs. Neuer 407% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73659/aktiencheck210224.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMkk1YkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--cf7414bf2f1c5277ec1fd5eff90f362af78a34da/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/aktiencheck210224.001.png?locale=de)
Eilt: Durchbruch in Krebsforschung: 100 mal wirksamer gegen Krebs. Neuer 407% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Durchbruch in Krebsforschung: 100 mal wirksamer gegen Krebs. Neuer 407% Biotech Hot Stock nach 15973% mit BioNTech
21.02.24
London (www.aktiencheck.de, Anzeige)
![Walmart’s uptrend is intact; buy it when it dips: https://www.marketbeat.com/logos/articles/med_20240220072702_chart-wmt-2202024ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOEE0YkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--f9fc570cfe7763f87a5f49b0d6576df12fcc1136/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240220072702_chart-wmt-2202024ver001.png?locale=de)
Walmart’s uptrend is intact; buy it when it dips
Walmart (NYSE: WMT) is in an uptrend and will likely continue. The Q4 results and guidance for 2024 underpin an expectation for capital returns and improving shareholder value for this retail
![These 5 stocks have unique competitive edge and room to run: https://www.marketbeat.com/logos/articles/med_20240219114803_these-5-stocks-have-unique-competitive-edge-and-ro.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBd000YkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--fe9fcb86392f7d933ed42d9dbe98e35ce5cff6fb/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240219114803_these-5-stocks-have-unique-competitive-edge-and-ro.jpg?locale=de)
These 5 stocks have unique competitive edge and room to run
A prominent investment theme of the past year is the outperformance of profitable companies with a unique competitive advantage.
Obvious examples of stocks in that category include Nvidia Corp.
![Warren Buffett goes ex-tech and pro-oil, sell Apple buy Chevron?: https://www.marketbeat.com/logos/articles/med_20240219110132_warren-buffett-goes-ex-tech-and-pro-oil-sell-apple.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBd3M0YkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--39e448efe4f51ea415418849db35e25467ded4a8/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240219110132_warren-buffett-goes-ex-tech-and-pro-oil-sell-apple.jpg?locale=de)
Warren Buffett goes ex-tech and pro-oil, sell Apple buy Chevron?
Every market brings you a cycle to take advantage of, that is for sure, and there will always be cycles to come. Warren Buffett has been quoted saying that timing the market can turn out to be a
![Sensation: 100 mal wirksamer gegen Krebs - Neuer 343% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73641/AC_VidacPharma_200224.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNWMzYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--0f27b75bb5a57d663b32ff33b7b10fac5f94f4d1/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC_VidacPharma_200224.001.png?locale=de)
Sensation: 100 mal wirksamer gegen Krebs - Neuer 343% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Sensation: 100 mal wirksamer gegen Krebs - Neuer 343% Biotech Hot Stock. Nach 15973% mit BioNTech und 134452% mit Biogen
20.02.24 08:03
London (www.aktiencheck.de, Anzeige)
![Best restaurant stocks to buy now: https://www.marketbeat.com/logos/articles/med_20240219102454_best-restaurant-stocks-to-buy-now.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMk0zYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--935ece3b7e1bf174383660a78d366321ab652941/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240219102454_best-restaurant-stocks-to-buy-now.jpg?locale=de)
Best restaurant stocks to buy now
Sinking your teeth into a juicy burger from your favorite fast-food chain is comfort food at its finest. But as an investor, capitalizing on a flourishing restaurant empire may prove even more
![Can UnitedHealth Group afford to keep Medicare Advantage plans?: https://www.marketbeat.com/logos/articles/med_20240218165851_can-unitedhealth-group-afford-to-keep-medicare-adv.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeHMzYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9daa919fb7df908639c9904a9681a2cd6724ae14/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240218165851_can-unitedhealth-group-afford-to-keep-medicare-adv.jpg?locale=de)
Can UnitedHealth Group afford to keep Medicare Advantage plans?
Medicare Advantage plans have been making headlines in 2024, but not in a positive light, at least for health insurance companies. Medicare is a government-sponsored health insurance benefit
![Marathon Oil stock is the place to be if you need value: https://www.marketbeat.com/logos/articles/med_20240218155954_marathon-oil-stock-is-the-place-to-be-if-you-need.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeDAzYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b69991fa08cb93eb6823cfb94305fc36289d26f4/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240218155954_marathon-oil-stock-is-the-place-to-be-if-you-need.jpg?locale=de)
Marathon Oil stock is the place to be if you need value
Not all stocks are created equal, and this year energy stocks could quickly become the market's favorite. A once-in-a-cycle opportunity to line up your portfolio with all the macro forces at play
![Eilt: Krebsmedikament bis zu 100 mal wirksamer - Kursrallye voraus. Neuer 343% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73629/Aktiencheck190224.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK3cyYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--5174116af69948105b50c8fccce0d90716fdfe0d/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Aktiencheck190224.001.png?locale=de)
Eilt: Krebsmedikament bis zu 100 mal wirksamer - Kursrallye voraus. Neuer 343% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Krebsmedikament bis zu 100 mal wirksamer - Kursrallye voraus. Neuer 343% Biotech Hot Stock nach 134452% mit Biogen
19.02.24
London (www.aktiencheck.de, Anzeige)
![Cisco Systems stock: Income investors buy the dip: https://www.marketbeat.com/logos/articles/med_20240215120254_chart-csco-2152024ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMFUxYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d6d9b84210723671d6aab280c23c86c84da5f3a7/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240215120254_chart-csco-2152024ver001.png?locale=de)
Cisco Systems stock: Income investors buy the dip
Cisco Systems (NASDAQ: CSCO) issued a decent FQ2 report but guided lower for Q3, leaving the market less than inspired. However cold the guide, someone is stepping into the buy the dip, and it
![Arista Networks stock soars past big tech rival Cisco: https://www.marketbeat.com/logos/articles/med_20240215184947_arista-networks-stock-soars-past-big-tech-rival-ci.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeTQxYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d12857997b983aac6219b44d8119db69090bed43/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240215184947_arista-networks-stock-soars-past-big-tech-rival-ci.jpg?locale=de)
Arista Networks stock soars past big tech rival Cisco
Arista Networks Inc. (NYSE: ANET) may not be as well known among tech investors as Cisco (NASDAQ: CSCO), but it's outperformed its larger rival by a wide margin in the past year.
Arista posted
![Eilt: Hautkrebs vollständig geheilt - Institutionelle Investoren vor Einstieg. Neuer 343% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73623/AC-160224.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBd0ExYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--6120e840c501df1c20958791490530268100d8c6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC-160224.001.png?locale=de)
Eilt: Hautkrebs vollständig geheilt - Institutionelle Investoren vor Einstieg. Neuer 343% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Hautkrebs vollständig geheilt - Institutionelle Investoren vor Einstieg. Neuer 343% Biotech Aktientip nach 15.973%
16.02.24 08:03
London (www.aktiencheck.de , Anzeige)
![Occidental Petroleum stock price is ready to gush higher: https://www.marketbeat.com/logos/articles/med_20240215093116_chart-oxy-2152024ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMUkwYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--23c0626be4fd092b7e8f5e823608991d74f68f5c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240215093116_chart-oxy-2152024ver001.png?locale=de)
Occidental Petroleum stock price is ready to gush higher
The Occidental Petroleum (NYSE: OXY) investment thesis has been getting more bullish over the last two years, setting the stock up for a substantial rally. Q4 results aside, the market appears
![Pfizer at 10-year support: Is it a massive buy opportunity?: https://www.marketbeat.com/logos/articles/med_20240212102305_pfizers-at-10-year-support-is-it-a-massive-buy-opp.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOVl6YkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--51d7c9ac7d793d4d12c78ac7dc61163962d9d9f6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240212102305_pfizers-at-10-year-support-is-it-a-massive-buy-opp.jpg?locale=de)
Pfizer at 10-year support: Is it a massive buy opportunity?
For shareholders of the multinational biotech giant Pfizer Inc. (NYSE: PFE), it might feel like the stock's all-time highs set during the pandemic were centuries ago. After making its
![Restaurant Brands expands its Burger King franchise empire: https://www.marketbeat.com/logos/articles/med_20240212111728_restaurant-brands-expands-its-burger-king-franchis.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOVV6YkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--5f6e33c72e5fcec3f8277ebb90cde0cdaaf9303b/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240212111728_restaurant-brands-expands-its-burger-king-franchis.jpg?locale=de)
Restaurant Brands expands its Burger King franchise empire
Quick-service restaurant company Restaurant Brands Inc. (NYSE: QSR) owns four well-known fast food brands, including Tim Hortons, Burger King, Popeyes Louisiana Kitchen and Firehouse Subs.
The
![Gene therapy: Why does it cost millions for a single treatment?: https://www.marketbeat.com/logos/articles/med_20240212110357_gene-therapy-why-does-it-cost-millions-for-a-singl.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBN2d6YkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--a39235526b52f3199b75e164e6ec5b30b6c3cf16/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240212110357_gene-therapy-why-does-it-cost-millions-for-a-singl.jpg?locale=de)
Gene therapy: Why does it cost millions for a single treatment?
Gene therapy treatments have been making major headlines as advances in gene editing have gone mainstream thanks to the advent of CRISPR/Cas-9 technology. The shot heard around the world in the
![How to use options calendar spreads to generate weekly income: https://www.marketbeat.com/logos/articles/med_20240214084820_option-cal-intc.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOTh5YkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--cc7b199bf8107c3e8d378eade23fd2d75e38c6e9/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240214084820_option-cal-intc.jpg?locale=de)
How to use options calendar spreads to generate weekly income
There are many ways to collect income from the stocks. Dividends first come to mind as they pay out a small percentage of the stock price and the number of shares you own in cash, usually on a
![Wall Street is surprisingly most bullish on these 3 Nasdaq stocks: https://www.marketbeat.com/logos/articles/med_20240213204601_wall-street-is-surprisingly-most-bullish-on-these.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNlF5YkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--5785a96f9d14a42639bfadd58728639d478cfe18/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240213204601_wall-street-is-surprisingly-most-bullish-on-these.jpg?locale=de)
Wall Street is surprisingly most bullish on these 3 Nasdaq stocks
Past performance doesn't guarantee future results. Or does it?
The age-old investment disclaimer is certainly being put to the test this year. Some of last year's biggest winners are off to hot
![Energy sector: assessing breakout potential and key players: https://www.marketbeat.com/logos/articles/med_20240213201016_energy-sector-assessing-breakout-potential-and-key.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNlV5YkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--43d412d248cbf72e06b9a542f85442a5784c5952/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240213201016_energy-sector-assessing-breakout-potential-and-key.jpg?locale=de)
Energy sector: assessing breakout potential and key players
As the overall market continues to ramp up and trade near all-time highs, one sector has quietly consolidated. The energy sector remains close to flat this year despite the recent melt-up
![Eilt: Biotech Hot Stock unmittelbar vor Big News. Durchbruch in Krebsforschung. Institutionelle Investoren vor Einstieg. Neuer 312% Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Bioge: https://www.irw-press.at/prcom/images/messages/2024/73599/AC_Vidac_140224.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBd1V5YkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--717aec45cbef192e5f25b1a7d68ed92622715912/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC_Vidac_140224.001.png?locale=de)
Eilt: Biotech Hot Stock unmittelbar vor Big News. Durchbruch in Krebsforschung. Institutionelle Investoren vor Einstieg. Neuer 312% Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Bioge
Eilt: Biotech Hot Stock unmittelbar vor Big News. Neuer 312% Biotech Aktientip nach 15.973% mit BioNTech ($BNTX)
14.02.24 08:03
London (www.aktiencheck.de, Anzeige)
Link